EICHORCondition: Solid Tumor Malignancies · Sponsor: Kumquat Biosciences Inc.
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The goal of this clinical trial is to learn if KQB168 works to treat advanced solid tumor cancer in adults. It will also learn about the safety of KQB168. The main questions it aims to answer are: * What is the safe dose of KQB168 by itself or in combination with pembrolizumab? * Does KQB168 alone or in combination with pembrolizumab decrease the size of the tumor? * What happens to KQB168 in the body? Participants will: * Take KQB168 daily, alone or in combination with pembrolizumab * Visit the clinic about 8 times in the first 8 weeks, and then once every 3 weeks after that
This description comes directly from the study's public registry record.
Kumquat Clinical Development · (858) 214-2700 · kumquatstudies@kumquatbio.com
Always discuss trial participation with your own doctor first.
| Mayo Clinic - Phoenix | Phoenix, Arizona, United States | Recruiting |
| USC Norris Comprehensive Cancer Center | Los Angeles, California, United States | Recruiting |
| Sarah Cannon Cancer Institute at HealthONE | Denver, Colorado, United States | Recruiting |
| Yale Cancer Center- New Haven | New Haven, Connecticut, United States | Recruiting |
| Mayo Clinic - Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Florida Cancer Specialists - Sarasota | Sarasota, Florida, United States | Recruiting |
| University of Iowa | Iowa City, Iowa, United States | Recruiting |
| Mayo Clinic - Rochester | Rochester, Minnesota, United States | Recruiting |
| Cleveland Clinic | Cleveland, Ohio, United States | Recruiting |
| NEXT Austin | Austin, Texas, United States | Recruiting |
| Mary Crowley Cancer Research Centers | Dallas, Texas, United States | Recruiting |
| UT MD Anderson Cancer Center - Houston | Houston, Texas, United States | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06994806